Efficacy of using thromboelastography to detect coagulation function and platelet function in patients with acute cerebral infarction
- PMID: 32757100
- DOI: 10.1007/s13760-020-01456-6
Efficacy of using thromboelastography to detect coagulation function and platelet function in patients with acute cerebral infarction
Abstract
Thromboelastography (TEG) is commonly used to predict coagulation state in patients with active bleeding. However, the correlation between TEG parameters and conventional tests in patients with cerebrovascular disease (CVD) remains unexplored. Here, we assessed the TEG values and their correlation with conventional tests in patients with acute cerebral infarction. Eighty-eight patients with acute cerebral infarction were enrolled from the Department of Neurology of Suzhou Medical School. Thirty healthy controls were enrolled from the preventive care department in the same hospital who were taking a physical examination. TEG 5000 thromboelastogram system was used to obtain TEG parameters. The automatic blood coagulation analyzer was used to measure the activated partial thromboplastin time (APTT), prothrombin time (PT), D-Dimer (DD) and fibrinogen (FIB) and platelet function. Among five TEG parameters, the R and K value decreased while MA value, alpha angle and CI value increased in patient group when compared with the healthy controls. The correlation between TEG parameters and conventional tests including DD, FIB, and platelet function are consistent with the high coagulation state in the patient group. Our results demonstrate that TEG parameters are sensitive indicators of high coagulation state in patients with acute cerebral infarction.
Keywords: CVD; Coagulation function; Correlation; Platelet function; TEG.
© 2020. Belgian Neurological Society.
References
-
- Kuzma E, Lourida I, Moore SF, Levine DA, Ukoumunne OC, Llewellyn DJ (2018) Stroke and dementia risk: a systematic review and meta-analysis. Alzheimers Dement 14:1416–1426. https://doi.org/10.1016/j.jalz.2018.06.3061 - DOI - PubMed - PMC
-
- Portegies ML, Koudstaal PJ, Ikram MA (2016) Cerebrovascular disease. Handb Clin Neurol 138:239–261. https://doi.org/10.1016/B978-0-12-802973-2.00014-8 - DOI - PubMed
-
- Hasan TF, Barrett KM, Brott TG, Badi MK, Lesser ER, Hodge DO, Meschia JF (2019) Severity of white matter hyperintensities and effects on all-cause mortality in the Mayo Clinic Florida Familial Cerebrovascular Diseases Registry. Mayo Clin Proc 94:408–416. https://doi.org/10.1016/j.mayocp.2018.10.024 - DOI - PubMed
-
- Schollnberger H, Eidemuller M, Cullings HM, Simonetto C, Neff F, Kaiser JC (2019) Correction to: dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003. Radiat Environ Biophys. https://doi.org/10.1007/s00411-019-00779-0 - DOI - PubMed - PMC
-
- Peng Q, Li HL, Wang Y, Lu WL (2019) Changing trend regarding the burden on cerebrovascular diseases between 1990 and 2016 in China. Zhonghua Liu Xing Bing Xue Za Zhi 40:400–405. https://doi.org/10.3760/cma.j.issn.0254-6450.2019.04.006 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
